Foley & Lardner LLP Public Affairs Director Jennifer Walsh and Partner Adria Warren are quoted in The American Journal of Managed Care article, “Stops and Starts Abound in the Oncology Payment Landscape,” discussing updates and considerations around several policies surrounding cancer treatment and the financial aspects of care.
Their comments provide an overview of Cures 2.0, the No Surprises Act, and the 340B drug pricing program, and are taken from their presentation at the Association of Community Cancer Centers (ACCC) 2023 Annual Meeting and Cancer Business Summit on the topic of “Emergent Payment Issues in Oncology.”